Published in Infect Immun on September 01, 1996
Effect of amphotericin B on larval growth of Echinococcus multilocularis. Antimicrob Agents Chemother (2003) 0.98
Long-term in vitro cultivation of Echinococcus multilocularis metacestodes under axenic conditions. Parasitol Res (2004) 0.95
Echinococcus multilocularis alkaline phosphatase as a marker for metacestode damage induced by in vitro drug treatment with albendazole sulfoxide and albendazole sulfone. Antimicrob Agents Chemother (2001) 0.93
In vitro activities of benzimidazoles against Echinococcus multilocularis metacestodes. Antimicrob Agents Chemother (1998) 0.91
In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae. Antimicrob Agents Chemother (2006) 0.87
The role of evolutionarily conserved signalling systems in Echinococcus multilocularis development and host-parasite interaction. Med Microbiol Immunol (2010) 0.85
myo-Inositol hexakisphosphate is a major component of an extracellular structure in the parasitic cestode Echinococcus granulosus. Biochem J (2002) 0.85
Quantitative screening for anticestode drugs based on changes in baseline enzyme secretion by Taenia crassiceps. Antimicrob Agents Chemother (2012) 0.81
Prevention and Immunotherapy of Secondary Murine Alveolar Echinococcosis Employing Recombinant EmP29 Antigen. PLoS Negl Trop Dis (2015) 0.76
An Echinococcus multilocularis Antigen B3 Proteoform That Shows Specific Antibody Responses to Active-Stage Alveolar Echinococcosis. J Clin Microbiol (2015) 0.76
In vitro culture of Echinococcus multilocularis producing protoscoleces and mouse infection with the cultured vesicles. Parasit Vectors (2016) 0.75
Preparation of isolated rat liver cells. Methods Cell Biol (1976) 17.96
Collagen substrata for studies on cell behavior. J Cell Biol (1972) 7.00
Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol Prog (1991) 3.21
Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J (1989) 2.89
Lumen formation by epithelial cell lines in response to collagen overlay: a morphogenetic model in culture. Proc Natl Acad Sci U S A (1982) 2.44
Immunology and morphology studies on the proliferation of in vitro cultivated Echinococcus multilocularis metacestodes. Parasitol Res (1995) 1.18
A stable long-term hepatocyte culture system for studies of physiologic processes: cytokine stimulation of the acute phase response in rat and human hepatocytes. Biotechnol Prog (1992) 1.03
Parthenogenesis and asexual multiplication among parasitic platyhelminths. Parasitology (1983) 1.01
Ultrastructural determination of cystogenesis by various Toxoplasma gondii isolates in cell culture. J Parasitol (1993) 0.95
[Studies on echinococcosis. 23. Electron microscopical observations on histogenesis of larval Echinococcus multilocularis]. Jpn J Vet Res (1970) 0.94
An established cell line of larval Echinococcus multilocularis. Int J Parasitol (1991) 0.83
Secretion of macrophage fusion factor (MFF) by schistosome egg granulomas maintained in vitro. Scand J Immunol (1992) 0.82
Interaction of filarial proteins on growth regulation of normal lung epithelial cells in vitro. Cell Biol Int (1995) 0.82
30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet (2006) 7.88
Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res (2001) 3.89
Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78
Modulation of cell surface sialic acid expression in Neisseria meningitidis via a transposable genetic element. EMBO J (1996) 2.80
Non-culture diagnosis and serogroup determination of meningococcal B and C infection by a sialyltransferase (siaD) PCR ELISA. Epidemiol Infect (1997) 2.67
European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol (2004) 2.65
Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway. J Biol Chem (1997) 2.57
Surgical treatment in proximal bile duct cancer. A single-center experience. Ann Surg (1996) 2.54
NZB mouse system for production of monoclonal antibodies to weak bacterial antigens: isolation of an IgG antibody to the polysaccharide capsules of Escherichia coli K1 and group B meningococci. Proc Natl Acad Sci U S A (1985) 2.49
Capsule phase variation in Neisseria meningitidis serogroup B by slipped-strand mispairing in the polysialyltransferase gene (siaD): correlation with bacterial invasion and the outbreak of meningococcal disease. Mol Microbiol (1996) 2.30
Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. J Infect Dis (1999) 2.04
Intuitive hypertext-based molecular identification of micro-organisms. Lancet (1999) 2.01
The large plasmids of Shiga-toxin-producing Escherichia coli (STEC) are highly variable genetic elements. Microbiology (1999) 1.97
Independent effects of IgG and complement upon human polymorphonuclear leukocyte function. J Immunol (1976) 1.97
"False-positive" anti-neutrophil cytoplasmic antibodies in HIV infection. Lancet (1990) 1.94
Detection of Mycoplasma pneumoniae by polymerase chain reaction and nonradioactive hybridization in microtiter plates. J Clin Microbiol (1993) 1.91
Contaminations occurring in fungal PCR assays. J Clin Microbiol (1999) 1.86
Benign liver tumors: differential diagnosis and indications for surgery. World J Surg (1997) 1.83
Contribution of genes from the capsule gene complex (cps) to lipooligosaccharide biosynthesis and serum resistance in Neisseria meningitidis. Mol Microbiol (1994) 1.82
Ultraviolet protection by summer textiles. Ultraviolet transmission measurements verified by determination of the minimal erythema dose with solar-simulated radiation. Br J Dermatol (2001) 1.81
Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. J Clin Microbiol (1998) 1.80
Low concentrations of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol Chem Hoppe Seyler (1989) 1.76
Mechanisms of neisserial serum resistance. Mol Microbiol (1999) 1.71
Molecular divergence of the sia locus in different serogroups of Neisseria meningitidis expressing polysialic acid capsules. Mol Gen Genet (1997) 1.68
Comparison of CT with diffusion-weighted MRI in patients with hyperacute stroke. Neuroradiology (2001) 1.68
Diagnostics of neisseriaceae and moraxellaceae by ribosomal DNA sequencing: ribosomal differentiation of medical microorganisms. J Clin Microbiol (2001) 1.66
Molecular analysis of the biosynthesis pathway of the alpha-2,8 polysialic acid capsule by Neisseria meningitidis serogroup B. Mol Microbiol (1994) 1.66
Escherichia coli O157:H7 and O157:H(-) strains that do not produce Shiga toxin: phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome. J Clin Microbiol (1999) 1.65
Complement factor C3 deposition and serum resistance in isogenic capsule and lipooligosaccharide sialic acid mutants of serogroup B Neisseria meningitidis. Infect Immun (1997) 1.65
Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Rheumatol Int (2011) 1.64
siaD PCR ELISA for confirmation and identification of serogroup Y and W135 meningococcal infections. FEMS Microbiol Lett (1998) 1.61
Acute disseminated encephalomyelitis following vaccination against human papilloma virus. Neurology (2009) 1.61
Genome search for susceptibility loci of common idiopathic generalised epilepsies. Hum Mol Genet (2000) 1.61
Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med (1996) 1.58
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology (1996) 1.53
Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg (1992) 1.53
Mutations of the DPC4/Smad4 gene in biliary tract carcinoma. Cancer Res (1998) 1.52
Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction. Br J Dermatol (2011) 1.51
Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med Microbiol Immunol (1996) 1.46
Influence of intraventricular fibrinolytic therapy with rt-PA on the long-term outcome of treated patients with spontaneous basal ganglia hemorrhage: a case-control study. Eur J Neurol (2008) 1.45
Does acute occlusion of the carotid T invariably have a poor outcome? Neurology (2004) 1.44
Dominant active alleles of RIM101 (PRR2) bypass the pH restriction on filamentation of Candida albicans. Mol Cell Biol (2000) 1.43
The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. Mol Immunol (2000) 1.43
Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. Vaccine (2001) 1.42
Persistent hypoglossal artery: MRI, MRA and digital subtraction angiography. Neuroradiology (2001) 1.42
Post-transformational rearrangement of an in vitro reconstructed group-A streptococcal erythromycin resistance plasmid. Plasmid (1979) 1.42
Molecular basis for distinction of the ET-15 clone within the ET-37 complex of Neisseria meningitidis. J Clin Microbiol (2000) 1.41
Glutaryl-coenzyme A dehydrogenase deficiency: a distinct encephalopathy. Pediatrics (1991) 1.41
Staphylococcus aureus in urine and false-positive immunoassay for Chlamydia. Lancet (1992) 1.39
["Second opinion centers". Approach for improving the quality of treatment for testicular tumors]. Urologe A (2006) 1.39
Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability. Drug Metab Dispos (1995) 1.39
Prevention of paraplegia during aortic operations. Ann Thorac Surg (1990) 1.38
[68-year-old female patient with dyspnea and hypokalemic hypertension]. Internist (Berl) (2007) 1.38
Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol (1999) 1.38
Cloning and characterisation of an immunodominant major surface antigen of Echinococcus multilocularis. Mol Biochem Parasitol (1991) 1.38
Rapid serogroup switching in Neisseria meningitidis. N Engl J Med (2000) 1.38
The role of galE in the biosynthesis and function of gonococcal lipopolysaccharide. Mol Microbiol (1993) 1.37
An epidemiologic survey of human alveolar echinococcosis in southwestern Germany. Römerstein Study Group. Am J Trop Med Hyg (1999) 1.36
Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology (2006) 1.36
Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation (2000) 1.35
Mannose-binding lectin regulates the inflammatory response of human professional phagocytes to Neisseria meningitidis serogroup B. J Infect Dis (2001) 1.35
New tumor-inhibiting metal complexes. Chemistry and antitumor properties. Met Based Drugs (1994) 1.33
Neospora caninum and Waddlia chondrophila strain 2032/99 in a septic stillborn calf. Vet Microbiol (2002) 1.31
Rapid PCR test for discriminating between Candida albicans and Candida dubliniensis isolates using primers derived from the pH-regulated PHR1 and PHR2 genes of C. albicans. J Clin Microbiol (1999) 1.31
Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res (1991) 1.28
Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res (2000) 1.27
Differential distribution of novel restriction-modification systems in clonal lineages of Neisseria meningitidis. J Bacteriol (2000) 1.26
Hepatotoxicity in patients prescribed efavirenz or nevirapine. Eur J Med Res (2008) 1.26
Secretory expression in Escherichia coli and Bacillus subtilis of human interferon alpha genes directed by staphylokinase signals. Mol Gen Genet (1989) 1.26
Molecular characterization of eukaryotic polysialyltransferase-1. Nature (1995) 1.25
Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates. Infect Immun (1999) 1.24
Evidence for the extended helical nature of polysaccharide epitopes. The 2.8 A resolution structure and thermodynamics of ligand binding of an antigen binding fragment specific for alpha-(2-->8)-polysialic acid. Biochemistry (1995) 1.24
S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J Biol Chem (1999) 1.24
Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study. Hepatology (1996) 1.23
Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann Neurol (1998) 1.23
Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol (1999) 1.22
Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology (1997) 1.21
Anti-endothelial serum antibodies in a patient with Susac's syndrome. J Neurol Sci (2009) 1.21
Site-specific insertion of IS1301 and distribution in Neisseria meningitidis strains. J Bacteriol (1996) 1.21
Physical and conformational properties of staphylokinase in solution. Biochim Biophys Acta (1993) 1.21
Genetic diversity of Neisseria lactamica strains from epidemiologically defined carriers. J Clin Microbiol (2001) 1.21
Oral naloxone reverses opioid-associated constipation. Pain (2000) 1.20
Lack of pharmacokinetic interaction as an equivalence problem. Int J Clin Pharmacol Ther Toxicol (1991) 1.19
Genetic isolation of meningococci of the electrophoretic type 37 complex. J Bacteriol (2001) 1.19
Prognostic factors in seminomas with special respect to HCG: results of a prospective multicenter study. Seminoma Study Group. Eur Urol (1999) 1.19
Stent placement for flow restoration in acute ischemic stroke: a single-center experience with the Solitaire stent system. AJNR Am J Neuroradiol (2011) 1.18
Diagnosis of Echinococcus multilocularis infection by reverse-transcription polymerase chain reaction. Gastroenterology (1995) 1.18
Neisseria meningitidis producing the Opc adhesin binds epithelial cell proteoglycan receptors. Mol Microbiol (1998) 1.18
Genetic rearrangement of FOXP1 is predominantly detected in a subset of diffuse large B-cell lymphomas with extranodal presentation. Leukemia (2006) 1.17
Systemic infection of an immunocompromised patient with Methylobacterium zatmanii. J Clin Microbiol (1999) 1.17
The influence of capsulation and lipooligosaccharide structure on neutrophil adhesion molecule expression and endothelial injury by Neisseria meningitidis. J Infect Dis (1996) 1.16
Cloning and functional characterization of a 30 kb gene locus required for lipopolysaccharide biosynthesis in Legionella pneumophila. Int J Med Microbiol (2000) 1.16
Functional characterization of an isogenic meningococcal alpha-2,3-sialyltransferase mutant: the role of lipooligosaccharide sialylation for serum resistance in serogroup B meningococci. Med Microbiol Immunol (1997) 1.15
The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein. Cancer Res (1999) 1.14
Expression of S100A12 (EN-RAGE) in cystic fibrosis. Thorax (2003) 1.14
Molecular cloning and functional expression of bacteriophage PK1E-encoded endoneuraminidase Endo NE. Mol Microbiol (1995) 1.13
Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol (1998) 1.13